Effectiveness and Safety of Mepitel Film in Managing Radiodermatitis: A Systematic Review and Meta-Analysis
-
By
-
Xue Ren
-
Hengjiao Wang
-
Jing Liu
-
YongXin Yuan
-
Tong Wu
-
Haibo Zhang
-
Defu Yang
-
Ying Yan
-
Ying Xu
-
Feng Wei
-
December 19, 2025
-
Clinical Scorecard: Effectiveness and Safety of Mepitel Film in Managing Radiodermatitis: A Systematic Review and Meta-Analysis
At a Glance
| Category | Detail |
|---|
| Condition | Radiodermatitis |
| Key Mechanisms | Radiation therapy-induced skin reactions including swelling, redness, and pain. |
| Target Population | Cancer patients undergoing radiation therapy. |
| Care Setting | Oncology clinics and hospitals. |
Key Highlights
- Mepitel film may reduce the incidence and severity of radiodermatitis.
- Effective in managing skin reactions such as blistering and erythema.
- Particularly beneficial for breast cancer patients receiving radiotherapy.
Guideline-Based Recommendations
Diagnosis
- Assess skin reactions using the Radiation-Induced Skin Reaction Assessment Scale (RISRAS).
Management
- Consider Mepitel film as a preventive measure for radiodermatitis in cancer patients.
Monitoring & Follow-up
- Regularly evaluate skin condition during and after radiation therapy.
Risks
- Monitor for potential adverse effects of Mepitel film, including skin irritation.
Patient & Prescribing Data
Cancer patients receiving radiotherapy.
Mepitel film can mitigate skin damage and improve patient comfort.
Clinical Best Practices
- Implement Mepitel film early in the radiation treatment process.
- Educate patients on skin care during radiation therapy.
References
